Market Place
Sourcing Support
Vivani Medical Announces Positive Preclinical Liver Fat Results GLP-1 Implant
04 Sep 2024 //
BUSINESSWIRE
Vivani Medical Reports Q2 2024 Results And Business Update
13 Aug 2024 //
BUSINESSWIRE
Vivani Medical Updates On Long-Term GLP-1 Obesity Implant Program
11 Jul 2024 //
BUSINESSWIRE
Vivani Gets FDA IND Clearance, Clinical Hold Lifted For GLP-1 Implant NPM-119
13 Jun 2024 //
BUSINESSWIRE
UK probes GLP-1 drugs` potential suicide risks
27 Jul 2023 //
FIERCE PHARMA
AstraZeneca`s once-weekly diabetes drug gets U.S. nod for children
27 Jul 2021 //
REUTERS
AstraZeneca sales hurt by Bydureon Bcise production constraints
03 Nov 2019 //
IN PHARMATECNOLOGISTS
Longtime Alkermes executive Elliot Ehrich joins Expansion Therapeutics
13 Nov 2018 //
FIERCE BIOTECH
Eli Lilly Strikes Deal for Diabetes Pill to Gain on Novo Nordisk
27 Sep 2018 //
XCONOMY
EU approves AZ’ Bydureon BCise device
30 Aug 2018 //
PHARMA TIMES
Repurposing a diabetes drug to slow Parkinson’s
23 Jul 2018 //
FIERCE BIOTECH
Type 2 diabetes research: fewer side effects from modified medication
18 Jul 2018 //
PHARMAPHORUM
New SR Exendin-4 Formulation proves effective against Parkinson`s
16 Jul 2018 //
BIOSPECTRUM
AZ hopes diabetes drug could be as effective as gastric band
11 Jul 2018 //
PHARMA PHORUM
Dr. Reddy`s and its US. subsidiary Promius announce the filing NDA for migraine
02 Apr 2018 //
BUSINESSWIRE
Stampeding generics expected to trample Lilly`s now-off-patent med Strattera
01 Jun 2017 //
FIERCE PHARMA
US FDA accepts Intarcia`s NDA for ITCA 650 to treat type 2 diabetes
07 Feb 2017 //
PHARMABIZ
Intarcia’s under skin mini-pump accepted by FDA
06 Feb 2017 //
PHARMA PHORUM
Glide raises £3.2m for solid dose injector programme
02 Feb 2017 //
PHARMATIMES
Platypus venom could give rise to a new class of diabetes treatments
30 Nov 2016 //
FIERCE BIOTECH
Oramed Vs. Novo Nordisk In Race For Oral GLP-1
29 Nov 2016 //
NASDAQ
AZ Taps 3SBio to Help Drive Sales of Diabetes Meds Byetta, Bydureon in China
14 Oct 2016 //
FIERCE PHARMA
Eli Lilly spurns a PhIII-ready diabetes drug, and Transition tanks
19 Apr 2016 //
FIERCE BIOTECH
Glide Announce Successful Proof-of-Concept With Novel Exenatide Formulation
05 Jan 2016 //
PR NEWS WIRE
Should FDA Penalize Drug Makers Over Diabetes Drug Ads?
01 Apr 2015 //
PHARMALOT
Sanofi`s Diabetes Franchise One Step Closer To U.S. Lyxumia Launch
20 Mar 2015 //
FIERCE PHARMA
AZ launches Bydureon Pre-Filled Injector Pen in UK
27 Jan 2015 //
PHARMA TIMES
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.